No results found for “”
No results found for filter “”
-
Statements & press releases 02.06.23
Digital therapeutics which could help transform patient care available only in a limited number of European...
Read more about our policy recommendations to improve access to these technologies across all Member States
Read Article -
Statements & press releases 02.06.23
EFPIA response to launch of Unitary Patent System in Europe
The Unitary Patent system is expected to stimulate research, development and investment in innovation, as well as to help to boost growth and competitiveness...
Read Article -
Statements & press releases 25.05.23
International Clinical Trials Day 2023
Without clinical trials, there can be no better treatments, no prevention and no cure.
Read Article -
Blog articles 25.05.23
About the importance of multistakeholder dialogue to advance clinical research and how Digital Health...
Endpoints are a key tool to evaluate treatment effect in clinical trials. It is essential that these endpoints reflect the patient’s lived experience with...
Read Article -
Blog articles 24.05.23
Time for more ambition on bladder cancer policy (Guest blog)
Feeling Unsure? Get Checked
Read Article -
Statements & press releases 23.05.23
Tackling therapeutic inertia in diabetes care: How we can improve outcomes
How local policies can compromise the ability to adhere to clinical guidelines, their impact and potential solutions
Read Article -
Statements & press releases 17.05.23
Pharma industry collaboration to reduce animal testing for medicinal products flourishing as more companies...
More data to help developing alternative methods to animal tests
Read Article -
Statements & press releases 16.05.23
Proposed Product Liability Directive revision may undermine Europe’s competitiveness
A joint statement
Read Article -
Blog articles 11.05.23
AMR and its impact on solid organ transplant recipients (Guest Blog)
AMR is a significant public health concern that can have a significant impact on the health outcomes of solid organ transplant recipients.
Read Article -
Statements & press releases 04.05.23
EFPIA Statement on improving the security of medicines supply in Europe
EFPIA statement on security of medicines supplies
Read Article -
Statements & press releases 28.04.23
Coalition of European partners urgently needed to fix tenfold variation in access to medicines across...
New pharmaceutical legislation linking intellectual property to launching medicines in 27 EU countries ineffective, impossible to enact and damaging to...
Read Article -
EFPIA News 27.04.23
IHI seeks patients and caregivers to contribute to its activities
IHI is calling on patients and informal caregivers to apply to be part of a new IHI Patient Pool which will strengthen IHI’s ties with the patient community,...
Read Article
No results found for “”
No results found for filter “”
-
EFPIA News 27.04.23
IHI seeks patients and caregivers to contribute to its activities
IHI is calling on patients and informal caregivers to apply to be part of a new IHI Patient Pool which will strengthen IHI’s ties with the patient community,...
Read Article -
EFPIA News 15.12.22
EFPIA survey among member companies on compliance with the EFPIA-PHRMA principles for responsible clinical...
EFPIA members continue to be committed to responsible clinical trial data sharing, for the benefit of patients and researchers
Read Article -
EFPIA News 13.12.22
IHI launches new funding round
The Innovative Health Initiative (IHI) has launched its third call for proposals, featuring topics covering rare diseases and mental health, and addressing...
Read Article -
EFPIA News 07.11.22
Europe’s share of global medicines R&D shrinks by a quarter in 20 years – as sector’s declining trends...
EFPIA is warning that the options being discussed by policy makers in the context of the EU Pharma Strategy fall well short of addressing concerns and...
Read Article -
EFPIA News 05.10.22
Pharmaceutical industry response to the war in Ukraine
Supporting people affected by the war
Read Article -
EFPIA News 16.06.22
European Multi-Stakeholder Sounding Board Meeting on “Innovation – The key to sustainable cancer care”...
Join the sounding board to discuss how high-quality care pathways and innovation can alleviate the pressure, improve sustainable patient access to high...
Read Article -
EFPIA News 24.05.22
RETHINKING Alzheimer’s disease project, calling for change in Alzheimer’s care, kicks off!
Now is the time to rethink Alzheimer’s disease to improve Alzheimer’s disease care pathway and the lives of people living with it.
Read Article -
EFPIA News 02.05.22
Roberta Savli appointed as Executive Director of Public Affairs at EFPIA
Roberta will take on the new role with immediate effect.
Read Article -
EFPIA News 28.04.22
EFPIA Recommendations on a Connected Data System in Europe
A connected health data ecosystem has the potential to empower more effective and efficient research and development of new treatments and diagnostics....
Read Article -
EFPIA News 22.04.22
Implementing “Good Lay Summary Practice”
Final report of the GLSP Workshop held on the 14, 15 & 21 February 2022.
Read Article -
EFPIA News 11.04.22
New proposals from the research-based pharmaceutical industry should reduce inequalities in patient access...
Europe's pharmaceutical sector is stepping up measures to help deliver faster, more equitable access to medicines for millions of patients across the EU....
Read Article -
EFPIA News 06.04.22
Shortening the WAIT - Patient Access to Medicines in Europe
Disparities in the time it takes for patients to access new medicines in different EU Member States are increasing.
Read Article
No results found for “”
No results found for filter “”
-
Statements & press releases 02.06.23
Digital therapeutics which could help transform patient care available only in a limited number of European...
Read more about our policy recommendations to improve access to these technologies across all Member States
Read Article -
Statements & press releases 02.06.23
EFPIA response to launch of Unitary Patent System in Europe
The Unitary Patent system is expected to stimulate research, development and investment in innovation, as well as to help to boost growth and competitiveness...
Read Article -
Statements & press releases 25.05.23
International Clinical Trials Day 2023
Without clinical trials, there can be no better treatments, no prevention and no cure.
Read Article -
Statements & press releases 23.05.23
Tackling therapeutic inertia in diabetes care: How we can improve outcomes
How local policies can compromise the ability to adhere to clinical guidelines, their impact and potential solutions
Read Article -
Statements & press releases 17.05.23
Pharma industry collaboration to reduce animal testing for medicinal products flourishing as more companies...
More data to help developing alternative methods to animal tests
Read Article -
Statements & press releases 16.05.23
Proposed Product Liability Directive revision may undermine Europe’s competitiveness
A joint statement
Read Article -
Statements & press releases 04.05.23
EFPIA Statement on improving the security of medicines supply in Europe
EFPIA statement on security of medicines supplies
Read Article -
Statements & press releases 28.04.23
Coalition of European partners urgently needed to fix tenfold variation in access to medicines across...
New pharmaceutical legislation linking intellectual property to launching medicines in 27 EU countries ineffective, impossible to enact and damaging to...
Read Article -
Statements & press releases 27.04.23
EFPIA response to the European Commission’s patent package proposal
Following proposals that will weaken the EU’s intellectual property framework in yesterday’s EU Pharmaceutical Legislation [26 April 2023], today’s release...
Read Article -
Statements & press releases 26.04.23
EU pharma-legislation risks sabotaging Europe’s life science industry putting European patients further...
EFPIA Response to the publication of the EU pharma legislation
Read Article -
Statements & press releases 21.03.23
EU long-term competitiveness strategy has to apply to the EU Pharma legislation
We would like to call on the Commission to stand by its commitment to the Long-term competitiveness of the EU and deliver a comprehensive competitiveness...
Read Article -
Statements & press releases 20.03.23
New European legislation designed to protect patients is delaying clinical trials for thousands of people...
The number of clinical trials delayed is expected to run into the hundreds, affecting up to 42,200 patients over the next three years, according to a survey...
Read Article
No results found for “”
No results found for filter “”
-
Blog articles 25.05.23
About the importance of multistakeholder dialogue to advance clinical research and how Digital Health...
Endpoints are a key tool to evaluate treatment effect in clinical trials. It is essential that these endpoints reflect the patient’s lived experience with...
Read Article -
Blog articles 24.05.23
Time for more ambition on bladder cancer policy (Guest blog)
Feeling Unsure? Get Checked
Read Article -
Blog articles 11.05.23
AMR and its impact on solid organ transplant recipients (Guest Blog)
AMR is a significant public health concern that can have a significant impact on the health outcomes of solid organ transplant recipients.
Read Article -
Blog articles 20.04.23
World Earth Day: Contributing to a more sustainable future
By making small changes in our daily lives, we can significantly reduce our carbon footprint and the impact of pharmaceuticals on the environment while...
Read Article -
Blog articles 13.04.23
Supporting the Head and Neck Cancer Community
April is Head & Neck Cancer Awareness Month, a chance for all of us to bring attention and resources to these deadly illnesses which, combined, make up...
Read Article -
Blog articles 05.04.23
Pharmaceutical Legislation: Two things that need to happen now
The industry needs this revision of the legislation. Not least to bring our regulatory framework in Europe up-to-date with the rapidly advancing science...
Read Article -
Blog articles 31.03.23
Breaking Down Barriers to Care in Myeloma (Guest blog)
The oncology community has proved that we can make exponential impact for patients, but it is imperative that we do more. As we develop ideas to help improve...
Read Article -
Blog articles 27.03.23
Mission on cancer - Sustainable, science based, efficient approach toward reducing cancer burden and...
The Mission’s on cancer aim is more prevention, better treatment, more lives saved, and a better quality of life for patients and their families living...
Read Article -
Blog articles 21.03.23
Why pull incentives are key to catalysing private investment into antibiotics (Guest blog)
The advent of antibiotics was one of the fundamental drivers of the shift in health care that has dramatically increased life expectancy and improved quality...
Read Article -
Blog articles 16.03.23
A modernised EU Variation Framework for enhancing the life of European patients
Regulatory Road to Innovation
Read Article -
Blog articles 16.03.23
Cross-stakeholder action is key to ensuring continued patient access to improved treatments in oncology...
Endpoints that measure time to disease progression or tumour shrinkage may provide a better approach to assessing novel therapies in oncology.
Read Article -
Blog articles 16.03.23
An inclusive discussion to design an ideal PULL mechanism (Guest Blog)
A silent pandemic is around the corner: antimicrobial resistance. The problem? The innovation engine, meant to provide the means to fight it, has stalled....
Read Article